MedPath

Colby Pharmaceutical Company

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects

Phase 2
Completed
Conditions
Influenza
Interventions
Biological: Fluzone® vaccine with JVRS-100 adjuvant or Fluzone alone
First Posted Date
2009-07-10
Last Posted Date
2011-02-14
Lead Sponsor
Colby Pharmaceutical Company
Target Recruit Count
472
Registration Number
NCT00936468

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

Phase 1
Completed
Conditions
Influenza
Interventions
Biological: Fluzone vaccine with JVRS-100 adjuvant
Biological: Fluzone vaccine
First Posted Date
2008-04-21
Last Posted Date
2010-03-17
Lead Sponsor
Colby Pharmaceutical Company
Target Recruit Count
128
Registration Number
NCT00662272
Locations
🇺🇸

Johnson County Clin-Trials, Lenexa, Kansas, United States

🇺🇸

Miami Research Associates, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath